Studies in gastric cancer mirrored this finding; the serum CLEC4M level is increased in patients with gastric cancer, especially in patients with liver metastasis, and CLEC4M levels strongly correlate with advanced pathological stage15. This evidence concerns the gene CLEC4M and gastric cancer.